Document is current
Any future updates will be listed below
-
Authors
Nishijima, Akira
Oda, Katsutoshi
Hasegawa, Kosei
Koso, Takahiro
Asada, Kayo
Ikeda, Yuji
Taguchi, Ayumi
Maeda, Daichi
Nagae, Genta
Tsuji, Shingo
Tatsuno, Kenji
Uehara, Yuriko
Kurosaki, Akira
Sato, Sho
Tanikawa, Michihiro
Sone, Kenbun
Mori, Mayuyo
Ikemura, Masako
Fujiwara, Keiichi
Ushiku, Tetsuo
Osuga, Yutaka
Aburatani, Hiroyuki
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (24K02584)
Japan Society for the Promotion of Science (24K02591)
Japan Agency for Medical Research and Development (JP19cm0106502)
- License Information
-
More Information
Article History
Received: 12 August 2023
Accepted: 8 August 2024
First Online: 13 August 2024
Competing interests
: K.O. reports grants from Konica Minolta received during the conduct of the study; grants and personal fees from AstraZeneca, personal fees from Chugai, grants from Takeda, outside the submitted work; K.H. reports grants and personal fees from Daiichi-Sankyo, grants from Yakult Honsha, grants from Pfizer, personal fees from Chugai, personal fees from AstraZeneca, outside the submitted work; K.F. reports grants and personal fees from Chugai-Roche, Astra Zeneca, Pfizer, Eisai, MSD, Taiho, Zeria, and Chugai, grants from Kaken, Shionogi, GSK, Lilly, Immunogen, and Oncotherapy, personal fees from Nihon Kayaku, Novartis, Kyowahakko Kirin, Janssen, Daiichi Sankyo, and Mochida, outside the submitted work. K.T. and H.A. report grants from Konica Minolta, outside the submitted work. All other authors declare no conflict of interest.
